Raymond James Financial Services Advisors, Inc. - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 176 filers reported holding ANTARES PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$347,000
+3.0%
84,605
-10.4%
0.00%0.0%
Q4 2021$337,000
-3.2%
94,448
-1.3%
0.00%0.0%
Q3 2021$348,000
-12.3%
95,703
+5.0%
0.00%0.0%
Q2 2021$397,000
+8.5%
91,142
+2.2%
0.00%0.0%
Q1 2021$366,000
-3.4%
89,138
-6.3%
0.00%0.0%
Q4 2020$379,000
-32.7%
95,099
-54.4%
0.00%
-50.0%
Q3 2020$563,000
-8.8%
208,350
-7.2%
0.00%0.0%
Q2 2020$617,000
+21.9%
224,472
+4.6%
0.00%0.0%
Q1 2020$506,000
+7.0%
214,577
+113.0%
0.00%0.0%
Q4 2019$473,000
+18.5%
100,741
-15.5%
0.00%
+100.0%
Q3 2019$399,000
+5.6%
119,240
+3.7%
0.00%0.0%
Q2 2019$378,000
+20.8%
115,016
+11.5%
0.00%0.0%
Q1 2019$313,000
-33.8%
103,136
-40.7%
0.00%
-50.0%
Q4 2018$473,000
+5.3%
173,979
+30.2%
0.00%0.0%
Q3 2018$449,000
+19.1%
133,614
-8.5%
0.00%0.0%
Q2 2018$377,000
+15.6%
146,034
-1.4%
0.00%0.0%
Q1 2018$326,000
-9.4%
148,046
-18.1%
0.00%0.0%
Q4 2017$360,000
-17.1%
180,666
+34.9%
0.00%
-33.3%
Q3 2017$434,000
+41.4%
133,900
+40.3%
0.00%
+50.0%
Q2 2017$307,00095,4250.00%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 6,400,000$13,312,0004.78%
GREAT POINT PARTNERS LLC 2,800,000$5,824,0002.27%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 18,389,789$38,251,0001.27%
WILLIAM HARRIS INVESTORS INC 1,534,283$3,191,0000.89%
Broadfin Capital, LLC 7,575,000$15,756,0000.85%
Lombard Odier Asset Management (USA) Corp 1,000,000$2,080,0000.15%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,665,738$3,465,0000.14%
JW Asset Management, LLC 142,198$296,0000.09%
Donald L. Hagan, LLC 44,000$92,0000.09%
DAFNA Capital Management LLC 45,000$94,0000.08%
View complete list of ANTARES PHARMA INC shareholders